(1)
In-Silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues As Dual Inhibitors Targeting Breast Cancer. AJPHS 2021, 11 (2), 2468-2474. https://doi.org/10.5530/ajphs.2021.11.9.